David Gerber, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Elevation Oncology
    Topic:
    Advisory Board
    Date added:
    05/16/2023
    Date updated:
    12/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Daichii Sankyo
    Topic:
    Data and Safety Monitoring Committee
    Date added:
    05/16/2023
    Date updated:
    12/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Intellectual Property Other
    Ineligible company:
    OncoSeer Diagnostics
    Topic:
    Biomarkers
    Date added:
    05/16/2023
    Date updated:
    12/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Jazz Pharmaceuticals
    Topic:
    Advisory Board
    Date added:
    07/30/2023
    Date updated:
    12/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astra Zeneca
    Topic:
    Advisory Board
    Date added:
    07/30/2023
    Date updated:
    12/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novocure
    Topic:
    Clinical trial
    Date added:
    07/30/2023
    Date updated:
    12/29/2023

Pages

Return to 162 Thoracic Oncology Tumor Board Conference (030824)